Hwail PharmaceuticalLtd Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Hwail PharmaceuticalLtd's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals Industry Growth | 11.3% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 31 Mar 2017 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Hwail PharmaceuticalLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 17 | 107,875 | 1,925 | 10,963 | 392 |
| 31 Dec 16 | 111,519 | 6,382 | 11,445 | 391 |
| 30 Sep 16 | 115,205 | 11,432 | 9,097 | 396 |
| 30 Jun 16 | 116,607 | 11,250 | 8,439 | 394 |
| 31 Mar 16 | 113,365 | 10,045 | 7,423 | 405 |
| 31 Dec 15 | 106,130 | 5,453 | 6,555 | 430 |
| 30 Sep 15 | 105,405 | 3,422 | 7,370 | 456 |
| 30 Jun 15 | 99,327 | 3,767 | 7,537 | 512 |
| 31 Mar 15 | 96,550 | 3,818 | 7,747 | 552 |
| 31 Dec 14 | 96,103 | 4,132 | 8,109 | 565 |
| 30 Sep 14 | 90,640 | 3,405 | 8,461 | 596 |
| 30 Jun 14 | 89,376 | 3,141 | 8,703 | 636 |
| 31 Mar 14 | 93,162 | 3,577 | 8,810 | 636 |
| 31 Dec 13 | 94,166 | 4,209 | 9,078 | 662 |
Quality Earnings: Insufficient data to determine if A061250 has high quality earnings.
Growing Profit Margin: Insufficient data to determine if A061250's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if A061250's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare A061250's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if A061250's earnings growth over the past year exceeded the Pharmaceuticals industry average.
Return on Equity
High ROE: A061250 has a negative Return on Equity (0%), as it is currently unprofitable.